Miranda Frith, PA
Surgical · Vestavia Hls, ALNPI 1538274238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.4% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.
Across 151 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$670
- Johnson & Johnson$522
- Regeneron Healthcare Solutions, Inc.$264
- Sanofi$260
- Sun Pharmaceutical Industries Inc.$197
- Lilly USA, LLC$171
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,86691%
- Education$2699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $670 |
| Johnson & Johnson | 23 | $522 |
| Regeneron Healthcare Solutions, Inc. | 12 | $264 |
| Sanofi | 11 | $260 |
| Sun Pharmaceutical Industries Inc. | 12 | $197 |
| Lilly USA, LLC | 8 | $171 |
| E.r. Squibb & Sons, L.L.C. | 7 | $136 |
| UCB, Inc. | 7 | $135 |
| Organogenesis Inc. | 6 | $127 |
| Pfizer | 5 | $96 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Amgen | 4 | $82 |
| LEO Pharma Inc. | 4 | $73 |
| Novartis | 3 | $66 |
| Boehringer Ingelheim | 3 | $53 |
| Almirall LLC | 2 | $44 |
| Galderma Laboratories, L.p. | 1 | $35 |
| Incyte Corporation | 2 | $29 |
| Biofrontera Inc. | 2 | $29 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $14 |
How this compares
$3,135 in reported general payments places this provider in the 85th percentile of 162 surgical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 241 | $4,288 |
| Tacrolimus | 18 | $3,030 |
| Clobetasol Propionate | 53 | $2,783 |
| Betamethasone Dipropionate | 35 | $1,156 |
| Metronidazole | 12 | $1,046 |
| Calcipotriene | 12 | $923 |
| Ammonium Lactate | 37 | $767 |
| Clindamycin Phosphate | 28 | $719 |
| Ciclopirox | 21 | $690 |
| Triamcinolone Acetonide | 77 | $658 |
| Doxycycline Hyclate | 30 | $576 |
| Fluconazole | 19 | $532 |
| Mupirocin | 64 | $471 |
| Hydroxyzine Hcl | 25 | $186 |
| Mometasone Furoate | 13 | $183 |
Paid to pharmacies, not to this prescriber.
Other surgical in Vestavia Hls
- Lauren RobinsonVestavia Hls$4K
- Michael CilimbergTuscaloosa$10K
- Heather ForsonBirmingham$8K
- Kelli HeerDothan$8K
- Suzanne Powe VickersBirmingham$8K
- Erica AbneyTuscaloosa$8K
- Jennifer RawlingsVestavia$7K
- Chelsi DavisJasper$7K
- Samuel MurphreeBirmingham$6K
- Michael JordanHuntsville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.